Trinity Biotech plc TRIB
NASDAQ
Recommendation
Dividend Power Score
Day's Range
$7.51$7.96
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 12/31/2024 | 12/31/2024 | 09/30/2024 | |||
|---|---|---|---|---|---|
| Net Income | -256.27% | -256.27% | 29.57% | ||
| Total Depreciation and Amortization | -28.76% | -28.76% | 290.85% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 456.72% | 456.72% | -36.89% | ||
| Change in Net Operating Assets | 441.65% | 441.65% | -212.31% | ||
| Cash from Operations | 192.44% | 192.44% | -229.45% | ||
| Capital Expenditure | -42.73% | -42.73% | -52.78% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | 13.80% | 13.80% | 3.33% | ||
| Cash from Investing | 11.80% | 11.80% | 2.05% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | 1.92% | 1.92% | -12.44% | ||
| Issuance of Common Stock | -92.34% | -92.34% | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | 96.58% | 96.58% | -10.86% | ||
| Cash from Financing | -57.47% | -57.47% | 8.38% | ||
| Foreign Exchange rate Adjustments | -1,940.00% | -1,940.00% | 104.63% | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 193.94% | 193.94% | -439.65% | ||